SEC Form 4/A · accession 0001062993-15-002354
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Thomas Wegman
Officer — President and Chief Executive · Director · 10% Owner
Period of report
Nov 12, 2014
Accepted (ET)
May 4, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1,F2 | Nov 12, 2014 | S | 27,700 | $39.0771 | D | 189,522 | D | |
| Common Stock, $0.001 par valueF3,F2 | Nov 13, 2014 | S | 4,300 | $39.0364 | D | 185,222 | D | |
| Common Stock, $0.001 par valueF2,F7 | Nov 14, 2014 | S | 8,000 | $38.50 | D | 174,822 | D | |
| Common Stock, $0.001 par valueF4 | holding | — | — | — | 1,005,178 | I | Held by the Edwin H. Wegman Marital Trust | |
| Common Stock, $0.001 par valueF5 | holding | — | — | — | 4,390 | I | Held by Jacob Wegman | |
| Common Stock, $0.001 par valueF6 | holding | — | — | — | 3,650 | I | Held by Sandra Wegman |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The selling price of $39.0771 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2These shares include 8,778 shares held by the reporting person and his wife, Mrs. Sandra Wegman, as joint tenants.
- F3The selling price of $39.0364 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.15. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4These shares are held in trust on behalf of the reporting person and Mrs. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
- F5These shares are held in a trust for the benefit of Mr. Jacob Wegman, a minor child residing in the home of the reporting person. The reporting person is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F6These shares are held by the wife of the reporting person, Ms. Sandra Wegman. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F7The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.